1. Home
  2. TTRX vs CURV Comparison

TTRX vs CURV Comparison

Compare TTRX & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.36

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Logo Torrid Holdings Inc.

CURV

Torrid Holdings Inc.

HOLD

Current Price

$2.00

Market Cap

159.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTRX
CURV
Founded
2015
2001
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
281.2M
159.2M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TTRX
CURV
Price
$9.36
$2.00
Analyst Decision
Strong Buy
Hold
Analyst Count
1
6
Target Price
$8.00
$1.59
AVG Volume (30 Days)
95.2K
301.7K
Earning Date
05-31-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,000,092,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.57
$0.94
52 Week High
$11.69
$2.94

Technical Indicators

Market Signals
Indicator
TTRX
CURV
Relative Strength Index (RSI) 73.27 58.14
Support Level $4.40 $1.03
Resistance Level N/A $2.23
Average True Range (ATR) 1.02 0.16
MACD 0.24 -0.00
Stochastic Oscillator 65.61 64.62

Price Performance

Historical Comparison
TTRX
CURV

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

About CURV Torrid Holdings Inc.

Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.

Share on Social Networks: